Azitra Inc. Receives NYSE American Non-Compliance Notice Over Stockholders’ Equity Requirements

Reuters

2025/10/04

<a href="https://laohu8.com/S/AZTR">Azitra Inc</a>. Receives NYSE American Non-Compliance Notice Over Stockholders' Equity Requirements

Azitra Inc. (NYSE American: AZTR), a clinical-stage biopharmaceutical company specializing in precision dermatology, announced that it has received a notice of non-compliance from the NYSE American stock exchange. The notice states that Azitra does not meet the continued listing requirement of maintaining at least $4 million in stockholders' equity, as outlined in Section 1003(a)(ii) of the NYSE American Company Guide, due to reported net losses in three of its last four fiscal years. Azitra has until October 31, 2025, to submit a plan to the exchange outlining steps to regain compliance by April 1, 2027. The notice does not immediately affect the trading or listing of Azitra's shares, nor its business operations or SEC reporting requirements. Azitra is currently exploring multiple funding options to address the issue.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Azitra Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001493152-25-016887), on October 03, 2025, and is solely responsible for the information contained therein.

应版权方要求，你需要登录查看该内容

登录 / 注册

免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。

热议股票

1
2
3
4
5
6
7
8
9
10

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/news/2572354186"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2572354186\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2572354186?lang=zh_CN&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-10-04 04:59","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2572354186","market":"nz","top_or_hot":-1,"title":"Azitra Inc. Receives NYSE American Non-Compliance Notice Over Stockholders’ Equity Requirements","media":"Reuters","content":"<html xmlns=\"http://www.w3.org/1999/xhtml\" xmlns:newsg2=\"http://iptc.org/std/nar/2006-10-01/\" xmlns:xhtml=\"http://www.w3.org/1999/xhtml\"><head><title>\n      <a href=\"https://laohu8.com/S/AZTR\">Azitra Inc</a>. Receives NYSE American Non-Compliance Notice Over Stockholders' Equity Requirements\n    </title></head><body><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<p>\n        Azitra Inc. (NYSE American: AZTR), a clinical-stage biopharmaceutical company specializing in precision dermatology, announced that it has received a notice of non-compliance from the NYSE American stock exchange. The notice states that Azitra does not meet the continued listing requirement of maintaining at least $4 million in stockholders' equity, as outlined in Section 1003(a)(ii) of the NYSE American Company Guide, due to reported net losses in three of its last four fiscal years. Azitra has until October 31, 2025, to submit a plan to the exchange outlining steps to regain compliance by April 1, 2027. The notice does not immediately affect the trading or listing of Azitra's shares, nor its business operations or SEC reporting requirements. Azitra is currently exploring multiple funding options to address the issue.\n      </p>\n</div><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<em>Disclaimer: <span>This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Azitra Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001493152-25-016887), on October 03, 2025, and is solely responsible for the information contained therein.</span></em>\n</div></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Azitra Inc. Receives NYSE American Non-Compliance Notice Over Stockholders’ Equity Requirements</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAzitra Inc. Receives NYSE American Non-Compliance Notice Over Stockholders’ Equity Requirements\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1032215980\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2025-10-04 04:59</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html xmlns=\"http://www.w3.org/1999/xhtml\" xmlns:newsg2=\"http://iptc.org/std/nar/2006-10-01/\" xmlns:xhtml=\"http://www.w3.org/1999/xhtml\"><head><title>\n      <a href=\"https://laohu8.com/S/AZTR\">Azitra Inc</a>. Receives NYSE American Non-Compliance Notice Over Stockholders' Equity Requirements\n    </title></head><body><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<p>\n        Azitra Inc. (NYSE American: AZTR), a clinical-stage biopharmaceutical company specializing in precision dermatology, announced that it has received a notice of non-compliance from the NYSE American stock exchange. The notice states that Azitra does not meet the continued listing requirement of maintaining at least $4 million in stockholders' equity, as outlined in Section 1003(a)(ii) of the NYSE American Company Guide, due to reported net losses in three of its last four fiscal years. Azitra has until October 31, 2025, to submit a plan to the exchange outlining steps to regain compliance by April 1, 2027. The notice does not immediately affect the trading or listing of Azitra's shares, nor its business operations or SEC reporting requirements. Azitra is currently exploring multiple funding options to address the issue.\n      </p>\n</div><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<em>Disclaimer: <span>This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Azitra Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001493152-25-016887), on October 03, 2025, and is solely responsible for the information contained therein.</span></em>\n</div></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"AZTR","symbol_name":"Azitra Inc","start_time":0,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251003:nNDL6ZFBPM:1","article_id":"2572354186","we_media_id":"1032215980","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2572354186","pubTimestamp":1759525181,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1032215980","head_image":"https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48"},"summary":"Azitra Inc. , a clinical-stage biopharmaceutical company specializing in precision dermatology, announced that it has received a notice of non-compliance from the NYSE American stock exchange. The notice states that Azitra does not meet the continued listing requirement of maintaining at least $4 million in stockholders' equity, as outlined in Section 1003 of the NYSE American Company Guide, due to reported net losses in three of its last four fiscal years. Azitra has until October 31, 2025, to submit a plan to the exchange outlining steps to regain compliance by April 1, 2027. The notice does not immediately affect the trading or listing of Azitra's shares, nor its business operations or SEC reporting requirements. Azitra is currently exploring multiple funding options to address the issue.","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"AZTR":"Azitra Inc","BK4139":"生物科技"},"translate_title":"Azitra Inc.收到纽约证券交易所美国公司关于股东权益要求的不合规通知","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"AZTR":0.9},"content_text":"Azitra Inc. Receives NYSE American Non-Compliance Notice Over Stockholders' Equity Requirements\n    \n\n        Azitra Inc. (NYSE American: AZTR), a clinical-stage biopharmaceutical company specializing in precision dermatology, announced that it has received a notice of non-compliance from the NYSE American stock exchange. The notice states that Azitra does not meet the continued listing requirement of maintaining at least $4 million in stockholders' equity, as outlined in Section 1003(a)(ii) of the NYSE American Company Guide, due to reported net losses in three of its last four fiscal years. Azitra has until October 31, 2025, to submit a plan to the exchange outlining steps to regain compliance by April 1, 2027. The notice does not immediately affect the trading or listing of Azitra's shares, nor its business operations or SEC reporting requirements. Azitra is currently exploring multiple funding options to address the issue.\n      \n\nDisclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Azitra Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001493152-25-016887), on October 03, 2025, and is solely responsible for the information contained therein.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-1","news_tag":"policyRegulatory,event","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":true,"code":"91000000","status":"200"}}}